Performer studies showed that CXCL5 induces EMT to promote CRC cell migration via activating ERK/Elk-1/Snail, and enhances infiltration by activating AKT/GSK3β, thereby inhibiting β-catenin degradation (Zhao et al., 2017). The gene discussed is ELK1; the disease is colorectal carcinoma.